MICRORNAS IN NEURODEGENERATIVE DISORDERS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20190276892A1
SERIAL NO

16251945

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are methods of treating a neurodegenerative disorder such as Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS) that include administering to a subject at least one inhibitory nucleic acid that decreases the level or activity of microRNA hsa-miR-155.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE GENERAL HOSPITAL CORPORATIONOFFICE OF TECHNOLOGY AFFAIRS 75 BLOSSOM STREET BOSTON MA 02114

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Berry, James Belmont, US 35 107
Butovsky, Oleg Boston, US 19 72
Cudkowicz, Merit Newton, US 4 22
Weiner, Howard Brookline, US 25 210

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation